Safety and Efficacy of Asfotase Alfa in Patients With Hypophosphatasia (HPP)
Clinical trial NCT02456038 · COMPLETED
Trial details
- NCT number
- NCT02456038
- Sponsor
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2015-07-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.